Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention Study

NCT03188705 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT03188705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention Study
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 4
Overall status
Completed
Start date
October 14, 2019
Completion date
January 17, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artery occlusion, aspirin sensitivity, cardiovascular diseases, clopidogrel, poor metabolism of, coronary artery disease, coronary disease, heart diseases, myocardial ischemia, platelet dysfunction, platelet thrombus